# Brown & Brown (BRO) — Financial Analysis

**Exchange:**   
**Coverage as of:** 2026-Q2  
**Updated:** 2026-06-03  
**Tier:** Free primer (step 2 of 19)  
**Sibling pages:** /stocks/bro/thesis · /memo/bro

## Financial Snapshot

---
source: coverage-next-full
ticker: BRO
step: 04
title: Financial Quality & Adversarial Sweep
created: 2026-06-03
---

### Step 04 — Financial Quality & Adversarial Research Sweep: Brown & Brown, Inc. (BRO)

#### 1. Financial Statement Quality Assessment

##### 1a. Revenue Recognition
BRO recognizes commission income when performance obligations are satisfied — generally at policy placement or renewal. Fee income is recognized as services are performed. Contingent commissions are recognized when the amount can be reasonably estimated and is probable (typically Q1 when carriers finalize profit-sharing calculations). [S1]

**Quality flags:** 
- Revenue recognition is relatively straightforward for an insurance broker — no complex percentage-of-completion or multi-element arrangements
- Contingent commission timing can create Q1 revenue lumpiness; manageable
- Post-Accession: acquired deferred revenue (~$1.05B in unearned revenue on FY2025 balance sheet vs. $577M prior year) — need to monitor for revenue pull-forward or timing adjustments in integration

##### 1b. Income Statement Adjustments

| Line Item | Issue | Adjustment |
|-----------|-------|-----------|
| Amortization of intangibles | Large non-cash charge ($178M+ in FY2024; ~$300M+ in FY2025 post-Accession) | Add back for EBITDAC — standard industry practice; intangible amortization reflects purchase price allocation, not economic value decline of relationships |
| Change in acquisition earnout estimates | Variable non-cash P&L item tied to contingent acquisition consideration | Add back for EBITDAC; excluded by management in "adjusted" metrics |
| Integration/restructuring costs | Non-recurring charges related to Accession integration | Management excludes from adjusted EPS; verify non-recurrence |
| Gain on disposal of business | $143M Davies Group gain in FY2023 | One-time; excludable from normalized earnings |
| Interest expense | $355M+ in FY2025 (up from ~$175M in FY2024); Accession debt-funded | Structural cost; must be included in levered valuation |

**Adjusted EPS vs. GAAP EPS divergence (FY2025):**
- GAAP diluted EPS: $3.16
- Adjusted diluted EPS: $4.26 (+34.8% premium to GAAP)
- Difference explains: ~$1.10/share from amortization of acquisition intangibles (~$0.85) + earnout adjustments (~$0.25)
- This divergence is expected and appropriate for an acquisition-heavy business. Investors should use adjusted EPS for operating performance but monitor goodwill/intangible quality. [S2]

##### 1c. Cash Flow Quality

| Metric | FY2023 | FY2024 | FY2025 |
|--------|--------|--------|--------|
| Operating Cash Flow | $1,010M | $1,174M | $1,450M |
| Net Income | $871M | $993M | $1,054M |
| OCF / Net Income | 1.16x | 1.18x | 1.38x |
| Free Cash Flow | $941M | $1,092M | $1,382M |
| FCF / Net Income | 1.08x | 1.10x | 1.31x |

**Cash flow quality: HIGH.** FCF conversion above 1x consistently signals earnings quality — the business generates more cash than reported GAAP earnings. The improvement in FY2025 conversion reflects D&A step-up from Accession + working capital benefits. [S2]

**Fiduciary funds note:** BRO holds substantial premium funds collected from clients (reported as "other current assets" and offset by "accounts payable" and other current liabilities). These are NOT operating cash flows and NOT financial leverage — they are fiduciary funds held in trust. This explains why the quick ratio (~0.30x) looks poor but is irrelevant to financial health.

---

#### 2. Balance Sheet Quality Assessment

##### 2a. Goodwill & Intangibles Analysis

| Item | FY2024 | FY2025 | Commentary |
|------|--------|--------|-----------|
| Goodwill | $7,970M | $15,087M | Doubled on Accession; represents ~50% of total assets |
| Intangibles (net) | $1,814M | $4,906M | Primarily purchased customer accounts (PCA); amortized over ~15–20 years |
| Total goodwill + intangibles | $9,784M | $19,993M | ~67% of total assets in FY2025 |
| Tangible book value | -$3,364M | -$7,446M | Deeply negative — expected for an intangible-heavy acquirer |

**Interpretation:** The goodwill and intangibles are almost entirely acquisition-related. For an insurance broker, the primary asset IS the customer relationship book — which GAAP labels as intangible. Tangible book value is meaningless for asset-light acquirers like BRO; what matters is whether the acquired cash flows (FCF yield on acquisition price) justify the purchase price. At ~16x EBITDA for Accession vs. 12x traded multiple, BRO paid a strategic premium — appropriate if specialty mix creates margin expansion that pays back the premium over 5–7 years. [S1][S2]

**Goodwill impairment risk:** BRO has not taken goodwill impairment in recent history. Given the underlying cash generation of acquired books, impairment risk is low unless organic growth deteriorates structurally or carrier relationships are lost materially. Post-Accession testing in FY2026 will be the first major test.

##### 2b. Debt Maturity Schedule

| Tranche | Amount (est.) | Maturity | Notes |
|---------|--------------|---------|-------|
| Current portion LT debt | ~$719M | 2026 | Refinancing risk: manageable given FCF |
| Term loan / Notes | ~$6,894M | 2027–2032 | Laddered maturity; multiple tranches |
| Finance leases | ~$243M | Various | Immaterial |
| **Total gross debt** | **~$7,856M** | | |

**Refinancing risk: LOW-MODERATE.** FCF of $1.4B/year well covers debt service; laddered maturities reduce roll risk. At 3.8x gross debt/EBITDAC, BRO is above management's 0–3x target range but within investment-grade territory. [S3]

---

#### 3. Adversarial Research Sweep

*Note: No earnings call transcripts available (coverage-next-full path). Adversarial research derived from filings, press releases, analyst commentary, and web searches.*

##### 3a. Short Selling / Negative Research Activity

**No material short-seller reports identified for BRO as of June 2026.** BRO is not a typical short-seller target because:
- Revenue is commission-based with actual economic services rendered (not financial engineering)
- 30+ years of audited public financials with consistent GAAP reporting
- Family-controlled business (Brown family ~10–15% directly + employee ownership) with long-term time horizons
- Low short interest historically (typically 1–3% of float)

**Closest thing to adversarial thesis:** The organic growth disappointment and Accession leverage are well-documented by sell-side analysts (see consensus file) but represent a valuation debate, not accounting fraud concerns. [S3]

##### 3b. Regulatory / Legal Investigations

**Howden Litigation (active as of 2026):** [S3]
- BRO disclosed litigation costs related to a dispute with Howden Group (UK insurance broker)
- Management cited ~$31M annualized revenue disruption from "Howden litigation startup costs" as a headwind in Q1 2026
- Details not fully public; appears related to a competitive conflict or non-solicitation dispute post-Accession
- **Assessment: Moderate concern.** $31M revenue impact is ~0.5% of annual revenue — manageable but bears monitoring. If litigation expands or continues, it could suppress specialty segment organic growth.

**Standard regulatory matters:** BRO is subject to routine insurance department investigations and occasional E&O (errors & omissions) claims. None have been material in recent years per 10-K risk factors. [S1]

**Commission transparency / contingent commission disclosures:** The insurance brokerage industry was investigated by NY AG Spitzer in 2004-2006 over undisclosed contingent commissions. BRO now discloses all contingent commission arrangements (compliant). No new regulatory actions on this front.

##### 3c. Contingent Commission Accounting

**Potential concern raised by analysts:** BRO recognizes contingent commissions when "reasonably estimable and probable." In years with large acquisitions, the addition of new contingent commission arrangements from acquired entities creates a potential for timing differences.

**Assessment:** Not a material risk. Contingent commissions are confirmed by carrier notification (typically Q1); the recognition is objective and auditor-reviewed. The $255M in FY2025 contingents is conservative vs. the $300M+ analysts model for FY2026 as Accession's book seasons. [S3]

##### 3d. Related-Party and Governance Concerns

**Brown family ownership concentration:** Hyatt Brown (founder/chairman) and family own a significant portion of shares (~10–15%). The Chairman and CEO roles are separated (Hyatt Brown / Powell Brown). [S4]

**Insider selling:** Hyatt Brown sold ~789,568 shares in 2024 for ~$81M — a large absolute amount but likely estate planning given his estimated remaining 35M+ share position. Director open-market purchases by three directors (Aug 2025 / May 2026) at current prices are modestly constructive. [S4]

**Assessment:** No governance red flags. Insider selling is consistent with estate planning at advanced age; three independent director purchases at current prices suggest confidence. The separated chair/CEO structure and >86% independent board are governance positives.

---

#### 4. Working Capital & Fiduciary Funds

| Item | FY2024 | FY2025 |
|------|--------|--------|
| Total Current Assets | $6,924M | $8,614M |
| Total Current Liabilities | $6,314M | $8,294M |
| Current Ratio | 1.10x | 1.04x |
| Quick Ratio (ex-other CA) | 0.25x | 0.30x |

**Do NOT be alarmed by the quick ratio.** The majority of current assets and liabilities are fiduciary premium funds (collected from clients, awaiting remittance to carriers) — these net to near zero economically. The operating working capital (receivables minus payables ex-fiduciary) is modestly positive and well-managed. [S2]

---

#### 5. Summary Financial Quality Assessment

| Dimension | Rating | Notes |
|-----------|--------|-------|
| Revenue quality | HIGH | Commission-based, recurring, transparent recognition |
| Earnings quality | HIGH | FCF > Net Income consistently; adjustments appropriate |
| Balance sheet quality | MODERATE-HIGH | Goodwill heavy but economically justified; leverage elevated post-Accession |
| Management credibility | MODERATE-HIGH | 30-year track record; Accession integration on track per Q1 2026 |
| Governance | HIGH | Separated chair/CEO; 86% independent board; good disclosure |
| Litigation risk | MODERATE | Howden litigation active; other matters routine |
| Short-seller / fraud risk | VERY LOW | No credible adversarial thesis identified |

---

#### Source Index

| Code | Source | Reference |
|------|--------|-----------|
| [S1] | SEC 10-K Filings | sec_filings/10K_FY2024_summary.md; 10K_FY2022_summary.md |
| [S2] | StockAnalysis.com | other/stockanalysis_summary.md |
| [S3] | Analyst Consensus / Market Data | other/consensus.md |
| [S4] | Proxy / Insider Transactions | proxy/governance_and_compensation.md; proxy/insider_transactions.md |

## Deeper Financial Analysis

The fundamental tier ($1.00) adds 8 dimensions not included here:

- Revenue Breakdown — segment revenue, geographic mix, product-line margins
- Financial Trends — QoQ momentum, leading indicators, inflection points
- Balance Sheet — debt structure, dilution risk, working capital dynamics
- Capital Allocation — ROIC, buyback cadence, reinvestment efficiency
- Earnings Analysis — beats/misses, guidance vs actuals, transcript highlights
- Competitive Positioning — market share, pricing power, peer benchmarks
- Industry Context — TAM, sector tailwinds/headwinds, regulatory backdrop

**API endpoint:** GET /api/v1/research/BRO/fundamental

## Navigation

- Overview: /stocks/bro
- Financials (this page): /stocks/bro/financials
- Thesis: /stocks/bro/thesis
- Investment Memo: /memo/bro
- Coverage universe: /stocks